B. Metzler seel. Sohn & Co. Holding AG Takes Position in Corteva, Inc. (NYSE:CTVA)

B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Corteva, Inc. (NYSE:CTVA - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,698,749 shares of the company's stock, valued at approximately $99,869,000. Corteva accounts for 1.0% of B. Metzler seel. Sohn & Co. Holding AG's portfolio, making the stock its 21st largest holding. B. Metzler seel. Sohn & Co. Holding AG owned 0.25% of Corteva as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CTVA. Acadian Asset Management LLC bought a new stake in shares of Corteva in the 1st quarter worth approximately $25,000. Capital Advisors Ltd. LLC lifted its stake in Corteva by 44.4% in the third quarter. Capital Advisors Ltd. LLC now owns 566 shares of the company's stock worth $33,000 after purchasing an additional 174 shares during the last quarter. Cultivar Capital Inc. purchased a new stake in Corteva during the second quarter valued at about $34,000. Redwood Wealth Management Group LLC bought a new position in shares of Corteva during the second quarter valued at about $43,000. Finally, Triad Wealth Partners LLC purchased a new position in shares of Corteva in the second quarter worth about $45,000. Institutional investors own 81.54% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on CTVA. Royal Bank of Canada reduced their price target on Corteva from $69.00 to $68.00 and set an "outperform" rating on the stock in a research report on Monday, November 11th. Bank of America raised shares of Corteva from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $59.00 to $67.00 in a research note on Wednesday, October 16th. KeyCorp dropped their price target on shares of Corteva from $66.00 to $62.00 and set an "overweight" rating for the company in a research report on Friday, August 2nd. Barclays raised their price target on shares of Corteva from $58.00 to $62.00 and gave the stock an "equal weight" rating in a report on Friday, November 8th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Corteva from $57.00 to $55.00 and set a "neutral" rating for the company in a research note on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $63.68.

Corteva Stock Up 2.2 %

Shares of NYSE:CTVA traded up $1.26 on Tuesday, hitting $58.25. 4,217,640 shares of the company traded hands, compared to its average volume of 3,277,418. The stock has a 50 day simple moving average of $58.36 and a 200-day simple moving average of $55.69. The company has a quick ratio of 0.96, a current ratio of 1.50 and a debt-to-equity ratio of 0.08. The company has a market cap of $40.03 billion, a PE ratio of 57.59, a PEG ratio of 1.77 and a beta of 0.77. Corteva, Inc. has a 52 week low of $43.89 and a 52 week high of $63.75.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Monday, December 2nd will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date is Monday, December 2nd. Corteva's dividend payout ratio (DPR) is 68.69%.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.